{"id":"W2339999281","doi":"10.3899/jrheum.150641","title":"New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol","year":2015,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Tumor necrosis factor alpha; Arthritis; Oncology; Immunology; Internal medicine; Adalimumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006083658,0.0006486811,0.001062993,0.00265507,0.0002870894,0.0008868243,0.0006634994,0.001107829,0.003038463],"category_scores_gemma":[0.0005569129,0.0002464344,0.0005889887,0.001816425,0.0004394689,0.00140543,0.0006664273,0.00251961,0.002137173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004653621,"about_ca_system_score_gemma":0.0006592196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006534735,"about_ca_topic_score_gemma":0.00145231,"domain_scores_codex":[0.9998069,0.00003548213,0.00003017821,0.00003062966,0.00008108581,0.00001575742],"domain_scores_gemma":[0.9997818,0.0001000559,0.00003255792,0.00000725384,0.00005509363,0.00002329038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009103349,0.0001214477,0.0001216134,0.01263834,0.00008077043,0.0002543787,0.00007617472,0.0002315086,0.002521716,0.00372314,0.02878623,0.9513537],"study_design_scores_gemma":[0.00003040932,0.0001268013,0.0004445728,0.002520625,0.00008004119,0.00160103,0.00005267097,0.00007215462,0.0004739592,0.001523,0.9930587,0.00001604717],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009105693,0.9986392,0.0001356162,0.0002980069,0.0002755264,0.000005004489,0.000009430505,0.000005806354,0.0005404262],"genre_scores_gemma":[0.0005294976,0.998157,0.0002359195,0.0002721785,0.0002538885,0.000006188704,0.0000204724,0.000001663738,0.0005232883],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003038463,"threshold_uncertainty_score":0.01016468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09187653286900763,"score_gpt":0.3158525180542813,"score_spread":0.2239759851852737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}